ArticleMolecular therapy oncolytics2020

The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism.

Martin McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.